The Efficacy and Tolerability of Once-daily Controlled-release Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality in Major Depressive Disorder By David V. Sheehan, MD, MBA; Anna Rozova, MSc, MD; E. Roderich Gossen, PhD; Michael Gibertini, PhD Abstract Trazodone Contramid® once-a-day (TzCOAD) is a reformulation of trazodone hydrochloride that controls the [...]
Psychopharmacology BULLETIN Newsletter the advance newsletter of Psychopharmacology BULLETIN Summary—Index of This Issue On-Press ORIGINAL RESEARCH EVIDENCE-BASED MEDICINEORIGINAL RESEARCH: The Trials and Travails Atypical Antipsychotic Drugs and Diabetes in the US Adverse Event Database Bipolar-I Patient Characteristics PTSD Following Short-Term Paroxetine Treatment Aripiprazole in the Treatment of PTSD Memantine: An [...]
• ORIGINAL RESEARCH • EVIDENCE BASED MEDICINE • GENERAL PSYCHIATRY Seroquel Once a Day: A Randomized, Double-Blind, Placebo-Controlled Study— This 6-week, randomized, double-blind study aimed to demonstrate efficacy of once-daily extended release quetiapine fumarate (quetiapine XR) versus placebo in patients with acute schizophrenia resulting in the efficacy of quetiapine XR [...]
Newsletter No. 3, 2008 www.psychopharmbulletin.com Volume 41 • Number 3 • 2008 Psychopharmacology BULLETIN Newsletter the advance newsletter of Psychopharmacology BULLETIN Summary—Index of This Issue On-Press ORIGINAL RESEARCH EVIDENCE BASED MEDICINE Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia abstract ~ Objective: To assess [...]
Newsletter No. 2, 2008 www.psychopharmbulletin.com Volume 41 • Number 2 • 2008 Psychopharmacology BULLETIN Newsletter the advance newsletter of Psychopharmacology BULLETIN Summary—Index of This Issue On-Press • ORIGINAL RESEARCH • EVIDENCE BASED MEDICINE Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy—p.2 [...]
• ORIGINAL RESEARCH • EVIDENCE BASED MEDICINE ORIGINAL RESEARCH: The Trials and Travails Placebo-Controlled — PTSD Double-Blind — ADHD Pilot-Controlled — GAD Comparative Analysis — ANTIDEPRESSANT TRIALS A Placebo-Controlled Trial of Guanfacine for the Treatment of PTSD in Veterans —p.2 Lori Davis, MD, L. Charles Ward, PhD, Ann Rasmusson, MD, [...]
Psychiatry in the Postgenomic Era Kathy L. Kopnisky, PhD Steven E. Hyman, MD Dr. Kopnisky is assistant to the director, and Dr. Hyman is director, both at the National Institute of Mental Health in Bethesda, MD. Abstract A rough draft of the human genome sequence is now available in the [...]
Pharmacogenomics of Antidepressants: Drug Discovery, Treatment, and Ethical Considerations Julio Licinio, MD Jonas Hannestad, MD, PhD Ma-Li Wong, MD Dr. Licinio is professor of psychiatry and biobehavioral sciences and medicine/endocrinology at the University of California School of Medicine in Los Angeles. He is also director of the University’s Interdepartmental Clinical [...]
THE ADVANCE NEWSLETTER OF PSYCHOPHARMACOLOGY BULLETIN Summary—Index of This Issue On-Press Newsletter No. 4, 2007 www.psychopharmbulletin.com Volume 40 • Number 3 • 2007 This newsletter is a synopsis of topical issues to be published in Psychopharmacology Bu l l e t i n. It is provided as a free service [...]
THE ADVANCE NEWSLETTER OF PSYCHOPHARMACOLOGY BULLETIN Summary—Index of This Issue On-Press Newsletter No. 5, 2007 www.psychopharmbulletin.com Volume 40 • Number 3 • 2007 This newsletter is a synopsis of topical issues to be published in Psychopharmacology Bu l l e t i n. It is provided as a free service [...]